Derivation of genetically stable mesenchymal stem cells from feline embryonic cell aggregates.
Wang X., Luo H., Ruan H., Wang B., Ling X., Chen S.
Animal Study on Scar, published in Vet J (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Vet J (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41490940
- DOI
- 10.1016/j.tvjl.2026.106546
Abstract (original English)
Mesenchymal stem cells (MSCs) are regarded as a fundamental component in the advancement of regenerative therapies for feline medicine. In this study, a novel protocol was established to derive MSCs from discarded feline embryos obtained post-ovariohysterectomy. Embryonic cell aggregates (EAs) were generated through collagenase digestion of embryos, followed by three-dimensional (3D) culture in complete medium containing 100 ng/mL basic fibroblast growth factor (bFGF). The EAs were subsequently plated on collagen-coated dishes to yield feline embryonic cell aggregate-derived MSCs (feEA-MSCs). Strong expression of characteristic MSCs markers CD73, CD90, and CD105 was demonstrated by surface marker analysis, with minimal expression of CD34 and HLA-DR. Furthermore, significantly higher mRNA expression of the pluripotency-associated transcription factors NANOG and SOX2 was exhibited by feEA-MSCs compared to adipose-derived MSCs (AD-MSCs) (P < 0.05). Consistent alkaline phosphatase activity was maintained by the cells, while a karyotypically normal state at passage 6 (2n = 38) was retained. Overall, this approach provides a source of feline MSCs with enhanced pluripotency characteristics, demonstrating significant potential for translational applications in regenerative medicine.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Clinical Applications of Autologous Fat Grafting in Pathological Hand Conditions.
Systematic Review with a reported sample of 7 on Osteoarthritis, Scar, published in J Hand Surg Asian Pac Vol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 7
J Hand Surg Asian Pac Vol - Level AMeta-analysisPubMed
Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.
Meta-analysis with a reported sample of 323 on Scar, published in Eur J Obstet Gynecol Reprod Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 323
Eur J Obstet Gynecol Reprod Biol - Level AMeta-analysisEurope PMC
Therapeutic value of mesenchymal stem cell-derived extracellular vesicles in hypertrophic and keloid scars: a systematic review and meta-analysis
Meta-analysis on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
Front Cell Dev Biol - Level AMeta-analysisPubMed
Efficacy and safety of autologous cell-based therapies for atrophic acne scar treatment: an updated systematic review and meta-analysis with in-depth methodological and clinical insights.
Meta-analysis with a reported sample of 500 on Chronic Wound, Scar, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 500
Front Cell Dev Biol - Level ASystematic ReviewEurope PMC
Comparative Efficacy and Safety of Fractional CO<sub>2</sub> Laser and Gold Microneedling Radiofrequency for Atrophic Acne Scars: A Systematic Review
Systematic Review on Chronic Wound, Scar, published in Skin Res Technol (2026) — summary generated from the PubMed abstract.
- 2026
Skin Res Technol - Level AMeta-analysisPubMed
Role of exosome therapy in reconstructive surgery: a review.
Meta-analysis on Chronic Wound, Scar, Immune Modulation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne)1 citations